{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:39Z","timestamp":1793608059385,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100021041","name":"American College of Allergy Asthma & Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.anai.2026.03.001","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:30:47Z","timestamp":1773189047000},"page":"651-657.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment for mild asthma: What matters to providers"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2428-7965","authenticated-orcid":false,"given":"Emma","family":"Greimann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Freigeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Wettenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Baptist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.anai.2026.03.001_bib0001","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1398-9995.2007.01394.x","article-title":"Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations","volume":"62","author":"Dusser","year":"2007","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.anai.2026.03.001_bib0002","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1164\/rccm.202304-0642ST","article-title":"Questions in mild asthma: an official American Thoracic Society research statement","volume":"207","author":"Mohan","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2026.03.001_bib0003","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.chest.2021.09.004","article-title":"Revisiting mild asthma: current knowledge and future needs","volume":"161","author":"Mohan","year":"2022","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.anai.2026.03.001_bib0004","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaci.2007.09.029","article-title":"Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007","volume":"120","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2026.03.001_bib0005","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"2020 Focused updates to the Asthma Management Guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group","volume":"146","author":"Cloutier","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2026.03.001_bib0006","unstructured":"Global Strategy for Asthma Management and Prevention; 2025. Accessed April 1, 2026. https:\/\/ginasthma.org\/wp-content\/uploads\/2025\/11\/GINA-Summary-Guide-2025-WEB_FINAL-WMS.pdf"},{"issue":"4","key":"10.1016\/j.anai.2026.03.001_bib0007","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1081-1206(10)60940-4","article-title":"Quality of care in patients with asthma and rhinitis treated by respiratory specialists and primary care physicians: a 3-year randomized and prospective follow-up study","volume":"97","author":"Backer","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.03.001_bib0008","article-title":"Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma","volume":"5","author":"Crossingham","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"10.1016\/j.anai.2026.03.001_bib0009","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJMoa1715274","article-title":"Inhaled combined budesonide-formoterol as needed in mild asthma","volume":"378","author":"O\u2019Byrne","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2026.03.001_bib0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12890-017-0401-y","article-title":"Efficacy of budesonide\/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment","volume":"17","author":"Jenkins","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"21","key":"10.1016\/j.anai.2026.03.001_bib0011","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","article-title":"Controlled trial of budesonide-formoterol as needed for mild asthma","volume":"380","author":"Beasley","year":"2019","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.anai.2026.03.001_bib0012","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1715275","article-title":"As-Needed budesonide-formoterol versus Maintenance budesonide in Mild Asthma","volume":"378","author":"Bateman","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2026.03.001_bib0013","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa2504544","article-title":"As-needed albuterol-budesonide in mild asthma","volume":"393","author":"LaForce","year":"2025","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.anai.2026.03.001_bib0014","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa063861","article-title":"Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma","volume":"356","author":"Papi","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2026.03.001_bib0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chest.2025.07.4089","article-title":"Intermittent asthma and risk of severe exacerbation in children","volume":"169","author":"Sheikh","year":"2026","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.anai.2026.03.001_bib0016","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.anai.2024.11.017","article-title":"Mild asthma-What matters to patients and parents","volume":"134","author":"Greimann","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.03.001_bib0017","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaip.2023.10.027","article-title":"Regulatory and insurance challenges must be overcome in the United States to meet global standards for asthma management","volume":"12","author":"Arora","year":"2024","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:43:56Z","timestamp":1793605436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120626000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1081120626000967"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2026.03.001","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment for mild asthma: What matters to providers","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2026.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}